Nachrichten zur Inovio Pharmaceuticals Inc. Aktie

Global Oral Transmucosal Drugs Market Size To Exceed USD 62.3 Billion By 2033 | CAGR Of 6.5%

The Global Oral Transmucosal Drugs Market Size was Valued at USD 33.2 Billion in 2023 and the Worldwide Oral Transmucosal…

Inovio Pharmaceuticals, Inc. (INO) Presents at 2024 RBC Capital Markets Global Healthcare Conference (Transcript)

…

Inovio Pharmaceuticals, Inc. (INO) The Citizens JMP Life Sciences Conference (Transcript)

…

Oppenheimer maintains price target on Inovio Pharmaceuticals stock By Investing.com

Oppenheimer maintains price target on Inovio Pharmaceuticals stock…

Inovio Pharmaceuticals (INO) Q1 2024 Earnings Call Transcript

INO earnings call for the period ending March 31, 2024.…

Inovio Pharmaceuticals, Inc. (INO) Q1 2024 Earnings Call Transcript

…

Inovio Pharmaceuticals, Inc. 2024 Q1 - Results - Earnings Call Presentation

…

Ausblick: Inovio Pharmaceuticals öffnet die Bücher zum abgelaufenen Quartal

Inovio Pharmaceuticals wird am 13.05.2024 das Zahlenwerk zum am 31.03.2024 abgelaufenen Jahresviertel vorstellen.In Sachen EPS gehen 5 Analysten von einem…

Inovio Pharmaceuticals: Neutral On INO-3107 Amidst Stock Dilution And High Valuation

…

Inovio Pharmaceuticals (INO) Q4 2023 Earnings Call Transcript

INO earnings call for the period ending December 31, 2023.…

Inovio Pharmaceuticals, Inc. (INO) Q4 2023 Earnings Call Transcript

…

Antisense and RNAi Therapeutics Market Size & Share Envisaged To Reach USD 18.43 Billion By 2032, at 17.8% CAGR Growth: Polaris Market Research

The global Antisense and RNAi Therapeutics Market size and share is currently valued at USD 4.34 billion in 2023. It…

Inovio Pharmaceuticals, Inc. (INO) CEO Jacque Shea Presents at Oppenheimer 34th Annual Healthcare Life Sciences Conference Transcript

…

Inovio Pharmaceuticals Inc. stock outperforms market on strong trading day

Shares of Inovio Pharmaceuticals Inc. rose 8.29% to $0.44 Friday, on what proved to be an all-around mixed trading session…

Inovio Pharmaceuticals (INO) Q3 2023 Earnings Call Transcript

INO earnings call for the period ending September 30, 2023.…

Inovio Pharmaceuticals, Inc. 2023 Q3 - Results - Earnings Call Presentation

…

Inovio Pharmaceuticals, Inc. (INO) Q3 2023 Earnings Call Transcript

…

Active Pharmaceutical Ingredients (API) Market Size to Surpass USD 349.2 Billion Growth by 2030, Exhibit a CAGR of 6.5%

[235 + Pages Report] According to a market research study published by The Brainy Insights, the demand analysis of Global…

Dextromethorphan Market revenue to reach USD 550 Million by 2035, says Research Nester

Leading dextromethorphan market players include AstraZeneca plc, FibroGen, Inc., Novartis AG, Abbott Laboratories, GlaxoSmithKline plc, F. Hoffmann-La Roche Ltd., Merck…

Inovio Pharmaceuticals (INO) Q2 2023 Earnings Call Transcript

INO earnings call for the period ending June 30, 2023....…

Inovio Pharmaceuticals Inc. Q2 Loss decreases, beats estimates

WASHINGTON (dpa-AFX) - Inovio Pharmaceuticals Inc. (INO) revealed Loss for second quarter that decreased from last year and beat the…

Form 8-K INOVIO PHARMACEUTICALS, For: Aug 09

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

INOVIO Announces Second Quarter 2023 Financial Results and Provides Strategic Update

Preparing to initiate pivotal Phase 3 trial of INO-3107 in adult RRP patients in first quarter of 2024; INO-3107 received…

Form 10-Q INOVIO PHARMACEUTICALS, For: Jun 30

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

INOVIO Reports Inducement Grants Under Inducement Plan

PLYMOUTH MEETING, Pa., Aug. 4, 2023 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines…

Inovio to shed 30% of staff in restructuring drive

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

INOVIO to Report Second Quarter 2023 Financial Results on August 9, 2023

PLYMOUTH MEETING, Pa., July 26, 2023 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines…

Form 8-K INOVIO PHARMACEUTICALS, For: Jun 23

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

INOVIO Announces Notice of Pendency and Proposed Settlement of Stockholder Derivative Actions

Plymouth Meeting, Pa., June 23, 2023 (GLOBE NEWSWIRE) -- INOVIO (NASDAQ:INO) has released the following pursuant to…

Russell 3000 rejig: InMode, Assertio among healthcare additions; Inovio, Bionano among deletions

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

SNDL, Invitae among additions to Russell microcap; Inovio, Bionano among deletions

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Why Inovio Pharmaceuticals Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket

Gainers Minerva Surgical, Inc. (NASDAQ: UTRS) shares rose 202.3% to $0.5499 in pre-market trading. Minerva Surgical was granted U.S. Patent…

Inovio: EU Grants Orphan Drug Designation For INO-3107

WASHINGTON (dpa-AFX) - Inovio (INO) said that the European Commission granted orphan drug designation for INO-3107, the companys product candidate…

Inovio wins orphan drug status for HPV-related candidate in Europe

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Form 8-K INOVIO PHARMACEUTICALS, For: May 16

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

All You Need to Know About Inovio (INO) Rating Upgrade to Buy

Inovio (INO) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the companys earnings prospects. This…

Inovio Pharmaceuticals (INO) Q1 2023 Earnings Call Transcript

INO earnings call for the period ending March 31, 2023....…

Inovio Pharmaceuticals Inc. Q1 Loss decreases, but misses estimates

WASHINGTON (dpa-AFX) - Inovio Pharmaceuticals Inc. (INO) reported Loss for first quarter that decreased from the same period last year…

INOVIO Reports First Quarter 2023 Financial Results and Operational Highlights

Announced additional positive data from Phase 1/2 trial for INO-3107 in recurrent respiratory papillomatosis patients Second cohort of trial showed…

INOVIO to Report First Quarter 2023 Financial Results on May 10, 2023

PLYMOUTH MEETING, Pa., April 28, 2023 /PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA…

INOVIO: COMP Issues Positive Opinion For Orphan Drug Designation In The EU For INO-3107

WASHINGTON (dpa-AFX) - INOVIO (INO) announced that the European Committee for Orphan Medicinal Products has provided a positive opinion on…

Inovio Presents Data From Phase 1b Trial With INO-4201 As Ebola Booster For RVSV-ZEBOV

WASHINGTON (dpa-AFX) - Inovio (INO) said that data from a Phase 1b trial evaluating INO-4201 as an Ebola booster vaccine…

Why Shares of Inovio Pharmaceuticals Were Down Tuesday

The biotech stock, still reeling from a failed clinical trial, hit a 52-week low....…

INOVIO Reports Inducement Grant Under Inducement Plan

PLYMOUTH MEETING, Pa., April 3, 2023 /PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA…

Insiderhandel: Aufsichtsrat verkauft Aktien von Inovio Pharmaceuticals im Wert von 6.708$

Weiner, David B. - Aufsichtsrat - Tag der Transaktion: 2023-03-13...…

Inovio stock rises amid mixed trial results for cervical lesions drug; Q4 clinical updates

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Inovio Pharmaceuticals (INO) Reports Q4 Loss, Lags Revenue Estimates

Inovio (INO) delivered earnings and revenue surprises of -31.25% and 72.59%, respectively, for the quarter ended December 2022. Do the…

Inovio Pharmaceuticals (INO) Q4 2022 Earnings Call Transcript

INO earnings call for the period ending December 31, 2022....…

Why Inovio (INO) Shares Are Moving After-Hours

After falling initially in after-hours trading on Wednesday, Inovio Pharmaceuticals Inc (NASDAQ: INO) shares are back up following the company report of worse-than-expected fourth-quarter…

Inovio Pharmaceuticals Inc. Q4 Loss decreases, but misses estimates

WASHINGTON (dpa-AFX) - Inovio Pharmaceuticals Inc. (INO) revealed Loss for fourth quarter that decreased from the same period last year…